GCSF after Kasai surgery for biliary atresia
Treatments studied
Part of Digestive system, Genetic & congenital clinical trials.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have biliary atresia (a liver bile duct problem from birth).
- They need to have a Kasai surgery to open the bile ducts.
- No major heart, kidney, lung, or brain problems.
- No sickle cell anemia or similar blood diseases.
- No active infection when starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving umbilical cord stem cells along with a standard surgery (Kasai procedure) helps infants with biliary atresia. It aims to see if this combination can improve outcomes for babies diagnosed early.
This study is testing whether stem cells can help infants with liver cirrhosis from biliary atresia (a blocked bile duct condition) who have already had Kasai surgery. It aims to see if stem cell therapy can improve liver function and reduce complications.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
This trial tests whether a special nutritional support formula rich in medium-chain fats can help infants with biliary atresia after the Kasai procedure. It may support feeding and liver recovery during the early months after surgery.
This study looks at a specific pre-surgery blood marker called FGF19 (and related liver blood tests) in children with biliary atresia. The goal is to see whether the blood results before surgery can help predict how well children recover after surgery.
Hear when a new Granulocyte Colony Stimulating Factor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.